Casma Therapeutics Stock

casmatx.comHealthcare / BioTech & PharmaFounded: 2017

Casma Therapeutics is a biopharma technology company that focuses on removal of damaged cell components to treat and prevent various diseases. Casma Therapeutics aims to reprogram autophagy methods, also known as the removal of infiltrates of cells that can damage and degrade them. The private company has brought together a team of clinical specialists and scientists all with a mission to treat patients where traditional drugs have failed.

Register To Buy and Sell Shares

For more details on financing and valuation for Casma Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Casma Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Casma Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Daniel Ory
Chief Medical Officer
Frank Gentile
Chief Operating Officer
Keith Dionne
Chief Executive Officer
Leon Murphy
Chief Scientific Officer

Board Members

Bob Tepper
Third Rock Ventures
Cary Pfeffer
Third Rock Ventures
Finny Kuruvilla
Eventide Funds
Gladys Nunez
Hiromichi Kimura
Independent Director
Millie Ray
The Column Group
Nagesh Mahanthappa
Scholar Rock, Inc.
Tomotaka Okino

Frequently Asked Questions About Casma Therapeutics’ Stock

Can you buy Casma Therapeutics’ stock?
Casma Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Casma Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Casma Therapeutics’ stock?
Yes, you can sell stock of a private company like Casma Therapeutics. Forge can help you sell your Casma Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Casma Therapeutics’ stock price?
Casma Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Casma Therapeutics’ private market stock price with Forge Data.
What is Casma Therapeutics’ stock ticker symbol?
Casma Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Casma Therapeutics Raises $46.0 M in Series C Funding
New investors participating in the round include Amgen Ventures, LLC, Astellas Venture Management, Eisai Co., Ltd., Euclidean Capital, Mirae Asset, and Ono Venture Investment.
Updated on: Feb 27, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.